You are on page 1of 1

a.

Professional
Faculty of Medicine University of Andalas Medical DoctorMD, 1989
Heidelberg University, Germany Community HealthMSc, 1995
Faculty of Medicine, University of IndonesiaPulmonologist2004
Faculty of Medicine University of Indonesia MedicinePhD, 2012

b. Appointments

▪ 2017 – Head of TB Assembly Asia Pasific Society of Respirology(APSR)
▪ 2017 – member of International Global Health Committee , American Thoracic Society (ATS)
▪ 2016 – Vice Chairman of TB Expert Committee Indonesia
▪ 2013 - 2017 Member of the Regional Advisory Committee on MDR-TB/rGLC, WHO SEARO

▪ 2015 - Head of Indonesia Society of Respirology/PDPI Jakarta Branch
▪ 2013 - Head of Pulmonary Infection Division, Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas of Indonesia,
▪ 2013 - Member of Steering Committee of INA RESPOND/National Institute of Health Research and Development
▪ 2013 - 2017 Research Coordinator at Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas of Indonesia,
▪ 2013 - Country Director: MECOR Indonesia (in collaboration with American Thoracic Society/ATS).
▪ 2010 - Head of Foreign Affair, Indonesia Respiratory Society, Head Quarter
▪ 2006 - Head of TB DOTS and MDR-TB Persahabatan Hospital Jakarta

c. Recent Publications
Van Kampen, SC., Susanto, NH., Simon, S., Astiti, SD., Chandra, R., Burhan, E., Farid, MN., Chittenden, K., Mustikawati, DE., Alisjahbana, B. (2015). Effects of Introducing XPert MTB/RIF on Diagnosis and
Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study. PLoS ONE, Volume 10(6).
Mori, T., Burhan, E. (2015). Supporting Progress Towards the Post-2015 Targets and Regional Tuberculosis Elimination: A Statement of Intent from the Third Meeting of the Asian TB Experts Community. Eur
Respir J, Volume 45(6), pg 1760-2.
Burhan, E., Ruesen, C., Ruslami, R., Ginanjar, A., Mangunnegoro, H., Ascobat, P., Donders, R., van Crevel, R., Aarnoutse, R. (2013). Isoniazid, rifampin, and pyrazinamide plasma concentrations in relation to
treatment response in Indonesian pulmonary tuberculosis patients. Antimicrob Agents Chemother, Volume 57(8), pg 3614-9.

e. Collaborators & Other Affiliations
(i) Collaborators
• CC. Yuan, The Union;
• E. Fair, Department of Critical Care and Respiratory Medicine, UCSF; FD. Melle, American Thoracic Society;
• KA. Hyder, Tuberculosis Department of Communicable Diseases WHO SEARO; L. Chen, Curry International TB Center, UCSF;
• P. Hopewell, Department of Critical Care and Respiratory Medicine, UCSF;
• SA. McCurdy, UCD Master of Public Health Program;
S. Shiddiqui, NIH;
• S. Buist, Oregon Health and Science University;
• T. Mori, Stop TB Partnership Japan Research Institute Tuberculosis (RIT) and Japan Anti-Tuberculosis Association (JATA);